News

ACELYRIN, INC., an innovative clinical-stage biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies, today…
Read More...

Lonza announced it has invested in additional microbial development capabilities in Switzerland. The investment will support increased capacity of development services targeting…
Read More...

SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced an exclusive, target-specific license and option agreement with LegoChem Biosciences Inc. a…
Read More...

Kala Pharmaceuticals, Inc. a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye,…
Read More...

Arranta Bio, a leading contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, announced the completion of the sale of its process development…
Read More...

Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, confirmed that Health Canada authorized the use of a booster dose of the Moderna…
Read More...

MimiVax LLC, a clinical-stage biotechnology company in Buffalo, NY, USA, developing immunotherapeutics for cancer and autoimmune diseases, announced today that the company has received…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced it has launched Revelar…
Read More...

Roche announced that the European Commission has granted a marketing authorisation for Ronapreve (casirivimab and imdevimab), for treating COVID-19 in adults and adolescents (from 12…
Read More...

InnoCare Pharma, a commercial-stage biotech company, announced today the Investigational New Drug (IND) clearance of its SHP2 (Src Homology 2 domain containing protein tyrosine…
Read More...

Johnson & Johnson announced its intent to separate the Company’s Consumer Health business, creating a new publicly traded company. The planned separation would create two global…
Read More...

AbbVie and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research. To date, the collaboration has led to…
Read More...

Roche announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of the antibody combination, Ronapreve…
Read More...

The National Institute for Health and Care Excellence (NICE) has published positive guidance, in the form of a Final Appraisal Determination (FAD), confirming that POTELIGEO…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the…
Read More...

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for Jardiance (empagliflozin) 10 mg, which is being…
Read More...

Organon and Forendo Pharma announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company…
Read More...

Valneva SE a specialty vaccine company, today announced that the European Commission (“EC”) has approved an agreement pursuant to which Valneva would supply up to 60 million doses of…
Read More...

Omnicell, Inc. a leading provider of medication management solutions and adherence tools for health systems and pharmacies, and Fresenius Kabi, a global health care company that…
Read More...